Search

Displaying results 5441 - 5450 of 10000 in total
  1. Drug

    Peruvoside

    go.drugbank.com/drugs/DB13756
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    Oxidized cellulose

    go.drugbank.com/drugs/DB13570
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Coumarin 120

    go.drugbank.com/drugs/DB08168
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Saralasin

    go.drugbank.com/drugs/DB06763
    Experimental

    Categories: Agents Acting on the Renin-Angiotensin System
  5. Drug

    Piroximone

    go.drugbank.com/drugs/DB19750
    Experimental

    Piroximone is a small molecule drug. Piroximone has a monoisotopic molecular weight of 217.09 Da.

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Mecrylate

    go.drugbank.com/drugs/DB21343
    Experimental

    Mecrylate is a small molecule drug. Mecrylate has a monoisotopic molecular weight of 111.03 Da.

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    IDD-3

    go.drugbank.com/drugs/DB05427
    Experimental

    IDD-3 is a therapeutic specific immunostimulant developed by IDM Pharma in partnership with sanofi-aventis. It consists of mature dendritic cells loaded with lysates from melanoma tumor cell lines.

  8. Drug

    ALKS 27

    go.drugbank.com/drugs/DB05752
    Experimental

    ALKS 27 is an inhaled formulation of trospium chloride for the treatment of chronic obstructive pulmonary disease (COPD).

  9. Drug

    Dialyzable leukocyte extract

    go.drugbank.com/drugs/DB16530
    Investigational

    It is thought to have widespread effects on the immune system, and effective in treating infections and immunological issues. … Transferon is comprised of several peptides mixed from human dialyzable leucocyte extracts and acts as an immunomodulator.

  10. Drug

    IDM-2

    go.drugbank.com/drugs/DB05293
    Experimental

    IDM produces MAK cells from the patient's own white blood cells by activating these cells ex vivo to allow them to recognize and destroy tumor cells.